CD8A and neoplasm: To test this hypothesis, we performed immunohistochemistry (IHC) to quantify the density of CD4+ T cells, CD8+ T cells, CD20+ B cells and CD45RO+ cells on 242 LARC tumor tissues from the NT cohort (Fig. 2a).